Browse regulations

Amends regulations governing the Australian Institute of Family Studies, a statutory research agency under family law, adjusting its governance, funding, or operational mechanisms.

A government-funded research body duplicates private and academic efforts, wastes taxpayer resources that could be used productively, and embodies nanny-state paternalism by having the state study families. The unseen costs include crowding out private research initiatives and opportunity costs of those funds.

Amendment to regulations governing the Australian Film, Television and Radio School, a government-funded institution providing education and training in creative media industries.

Government subsidies for specialized industry training distort market signals, create unfair competition with private providers, and force taxpayers to fund a specific sector. The creative industries can and should fund their own training through market mechanisms; government involvement misallocates resources, reduces efficiency, and entrench dependency.

Regulations governing the Australian Film Commission's operations, including funding allocation, eligibility criteria, and content requirements for supported film productions, aimed at promoting Australian cultural content through subsidies and grants.

These regulations impose compliance burdens on filmmakers, distort market incentives by favoring government-approved projects over audience demand, and waste taxpayer funds on non-competitive productions. The unseen cost is the crowding out of private investment and the entrenchment of bureaucratic priorities over creative freedom, ultimately weakening the industry's global competitiveness.

Amendment to fisheries management regulations introduced in 2002, likely establishing catch quotas, licensing requirements, gear restrictions, reporting obligations, and sustainability measures for Australian fisheries.

Fisheries management through government quotas and licensing creates artificial scarcity, imposes substantial compliance costs on fishermen, and generates regulatory capture where established operators block competition. Market-based property rights, such as individual transferable quotas established through voluntary agreements, would achieve sustainable outcomes with far less bureaucracy. The approval timelines and reporting burdens disproportionately harm small operators and remote fishing communities while doing little to prevent the tragedy of the commons that open-access fisheries suffer from. Eliminating these restrictions would unleash innovation in fishing practices, reduce costs passed to consumers, and allow voluntary conservation efforts driven by actual resource owners rather than bureaucrats.

Amendment to regulations governing the collection of levies and charges from primary industries, modifying administrative and enforcement mechanisms for fee collection.

Directly extracts wealth from Australia's most productive sectors, imposing compliance costs and financial burdens that discourage investment; unseen effects include market distortions, reduced capital formation, and weakened competitiveness in industries vital to national prosperity.

Amends excise levy rates or conditions for primary industries (agriculture, mining, etc.).

Excise levies raise production costs, harm competitiveness, and distort resource allocation in the sectors that drive Australia's prosperity. Keeping it suppresses output, increases consumer prices, and reduces investment in primary industries.

Instrument metadata only: title indicates amendment to customs charges for primary industries, registered 2005. No substantive provisions available for review.

Old amendment (2002) likely obsolete; maintaining it adds legal complexity and compliance burden without contemporary justification. Repeal reduces regulatory clutter and search costs for businesses.

This regulation repeals the Tobacco Charge Regulations (2002), eliminating charges/fees associated with tobacco products.

Deleting this repeal instrument would create legal uncertainty around the continued validity of the tobacco charge repeal, potentially leading to attempts to revive those charges or confusion among affected parties. It achieves deregulation through a clear legislative act; removing it would undermine that deregulatory outcome.

Establishes a compulsory levy on shipping operators to fund rehabilitation and compensation for injured or ill seafarers through a government-managed scheme, providing benefits regardless of employer fault or solvency.

Imposes a coercive tax on a critical export sector, inflating maritime transport costs that ripple through the economy. Creates a bureaucratic fund that distorts employer incentives (reducing care for safety) and employee behavior (moral hazard). Compliance burdens fall disproportionately on smaller operators and amplify existing geographic disadvantages. Private insurance markets could provide more efficient, tailored coverage without state intermediation, preserving liberty while potentially lowering costs and improving outcomes through competition.

Regulation establishes the levy collection mechanism to fund the Seafarers Rehabilitation and Compensation Scheme, requiring employers to pay levies to finance rehabilitation services and compensation for injured or deceased seafarers.

Mandatory levy imposes compliance costs on shipping operators, distorts market incentives, crowds out private insurance solutions, and duplicates state compensation frameworks. Unseen consequences include reduced maritime competitiveness, higher consumer costs, and suppressed innovation in risk management products.

Amends Retirement Savings Accounts Regulations 1997, modifying requirements for RSA providers, investment restrictions, fee structures, and disclosure obligations to maintain RSAs as a simple, low-cost retirement savings product with government-prescribed features.

The regulation imposes compliance costs that reduce retirement savings returns, stifles innovation and competition by dictating product features, and substitutes bureaucratic judgment for consumer and provider choice. These distortions particularly harm low-balance savers through higher fees and fewer options, while the intended simplicity and consumer protection goals are better achieved through market competition and reputation mechanisms.

The Life Insurance Amendment Regulations 2002 (No. 2) amend the Life Insurance Regulations 1995 to tighten capital adequacy, increase financial reporting frequency, and expand product disclosure obligations, adding to the regulatory burden on life insurers.

These regulations increase compliance costs, leading to higher premiums and less innovation. They create barriers to entry that protect incumbents, reduce competition, and distort market signals. The intended consumer benefits are better delivered by market forces and private oversight, not government mandates.

Amendment to the Corporations Regulations altering the fees payable for corporate services, filings, and transactions under the Corporations Act 2001.

Fee regulations artificially raise the cost of corporate activities, creating unnecessary compliance burdens and perverse incentives that hinder entrepreneurship and distort market outcomes. The revenue could be raised more efficiently through general taxation or a streamlined cost-recovery mechanism without ongoing legislative amendments.

Amendment to Corporations Regulations with no content provided; cannot determine scope or mechanisms.

Insufficient information to justify keeping; burden of proof lies with regulator to demonstrate necessity. Default to deletion given that any expansion of corporate regulation likely adds compliance costs, reduces business flexibility, and creates barriers to entry without clear evidence of addressing market failures.

Amendment to therapeutic goods regulations - likely modifies approval processes, manufacturing standards, advertising restrictions, or compliance requirements for medicines and medical devices.

Therapeutic goods regulations create artificial barriers to entry, prolong approval timelines (often years), add billions in compliance costs, and restrict consumer access to potentially life-saving treatments. These regulations protect incumbent pharmaceutical companies from competition while delivering questionable safety benefits that could be achieved through liability systems, reputation, and market mechanisms. The costs include delayed access to treatments, inflated prices, suppressed innovation, and denied choices for patients with serious conditions who cannot wait for bureaucratic approvals. Distance and duplication with state regulations multiply these burdens for rural and remote Australian businesses.